Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease
Holly A. Bolton, … , Elena Shklovskaya, Barbara Fazekas de St. Groth
Holly A. Bolton, … , Elena Shklovskaya, Barbara Fazekas de St. Groth
Published August 24, 2015
Citation Information: J Clin Invest. 2015;125(9):3627-3641. https://doi.org/10.1172/JCI76031.
View: Text | PDF
Research Article Immunology

Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease

  • Text
  • PDF
Abstract

Regulatory T cells (Tregs) have been shown to enhance immune reconstitution and prevent graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation; however, it is unclear how Tregs mediate these effects. Here, we developed a model to examine the mechanism of Treg-dependent regulation of immune reconstitution. Lymphopenic mice were selectively reconstituted with Tregs prior to transfer of conventional CD4+ T cells. Full Treg reconstitution prevented the rapid oligoclonal proliferation that gives rise to pathogenic CD4 effector T cells, while preserving the slow homeostatic form of lymphopenia-induced peripheral expansion that repopulates a diverse peripheral T cell pool. Treg-mediated CTLA-4–dependent downregulation of CD80/CD86 on DCs was critical for inhibition of rapid proliferation and was a function of the Treg/DC ratio achieved by reconstitution. In an allogeneic BM transplant model, selective Treg reconstitution before T cell transfer also normalized DC costimulation and provided complete protection against GVHD. In contrast, cotransfer of Tregs was not protective. Our results indicate that achieving optimal recovery from lymphopenia should aim to improve early Treg reconstitution in order to increase the relative number of Tregs to DCs and thereby inhibit spontaneous oligoclonal T cell proliferation.

Authors

Holly A. Bolton, Erhua Zhu, Alexandra M. Terry, Thomas V. Guy, Woon-Puay Koh, Sioh-Yang Tan, Carl A. Power, Patrick Bertolino, Katharina Lahl, Tim Sparwasser, Elena Shklovskaya, Barbara Fazekas de St. Groth

×

Figure 1

Effect on rapid-phase LIP of reconstitution of the Treg compartment prior to T cell transfer.

Options: View larger image (or click on image) Download as PowerPoint
Effect on rapid-phase LIP of reconstitution of the Treg compartment prio...
Lymphopenic Rag–/– mice were reconstituted with purified Tregs by adoptively transferring either 0.25 × 106, 0.5 × 106, 1.25 × 106, or 2.5 × 106 bead-selected CD4+CD25+ Tregs. Mice were treated with IL-2/JES6-1 complexes second daily to support Treg expansion. (A) Donor cells were distinguished from host cells by a CD45 allelic difference. Shown is expression of CD25 and Foxp3 on donor CD4+ T cells in pLN (n = 4 per group). (B) The total number of CD4+CD25+Foxp3+ Tregs was calculated for each Treg dose in pLN, mLN, and spleen of Treg-reconstituted mice, and for WT controls (n = 4 per group). Data in A and B are from a single experiment. The comparison of WT, Rag–/– mice, and Rag–/– mice reconstituted with 2.5 × 106 CD4+CD25+ Tregs is representative of more than 10 independent experiments. (C) At day 7 after Treg transfer, 1 × 106 CFSE-labeled CD4+CD25– conventional T cells were adoptively transferred into unreconstituted or Treg-reconstituted Rag–/– mice, as described for A. All mice were treated with second daily IL-2/JES6-1 complexes throughout the experiment. Representative CFSE division profiles of conventional CD4+ T cells are shown at 7 days after transfer (left panels). (D) The ratio of CFSE– cells (>7 rounds of division) to CFSE+ T cells (0–3 rounds of division) was calculated. Data in C and D are from one experiment with n = 3–4 per group. (E) Comparison of the ratio of divided to undivided cells in the pLN, mLN, and spleen of unreconstituted or Treg-reconstituted Rag–/– mice. Data are pooled from 6 independent experiments (n = 9–19 per group). Data in B and D were analyzed using one-way ANOVA with a Newman-Keuls post-test, while data in E were analyzed using a 2-tailed unpaired t test. Bars represent mean ± SEM with individual values indicated by the open circles. *P < 0.05, **P < 0.01, and ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts